Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 933

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 933
---
 notes are an integral part of these unaudited condensed financial statements. F-116

TABLE OF CONTENTS Tvardi Therapeutics, Inc. CONDENSED Statements of Redeemable Convertible Preferred Stock
and Stockholders’ Deficit
(Amounts in thousands, except share amounts)
(Unaudited)

| ​                                 
 ​                                 | ​ 
 ​ | ​ 
 ​ | Redeemable ConvertiblePreferred Stock 
 Shares                                |   |            |   | ​ | ​ | Amount |   |        |   | ​ 
 ​ | ​ 
 ​ | ​ 
 ​ | Common Stock 
 Shares       |   |            |   | ​ | ​ | Amount |   |    |   | ​ 
 ​ | ​ | AdditionalPaid-InCapital |   |       |   | ​ | ​ | AccumulatedDeficit |   |         |   | ​ | ​ | AccumulatedOtherComprehensiveLoss |   |   |   | ​ | ​ | TotalStockholders’Deficit |   |         |   | ​ |
|:----------------------------------|:--|:--|:--------------------------------------|:--|-----------:|:--|:--|:--|:-------|:--|-------:|:--|:--|:--|:--|:-------------|:--|-----------:|:--|:--|:--|:-------|:--|---:|:--|:--|:--|:-------------------------|:--|------:|:--|:--|:--|:-------------------|:--|--------:|:--|:--|:--|:----------------------------------|:--|:--|:--|:--|:--|:--------------------------|:--|--------:|:--|:--|
| Balances as of January 1, 2024    | ​ | ​ | ​                                     | ​ | 29,555,538 | ​ | ​ | ​ | ​      | $ | 85,503 | ​ | ​ | ​ | ​ | ​            | ​ | 19,134,164 | ​ | ​ | ​ | ​      | $ | 19 | ​ | ​ | ​ | ​                        | $ |   762 | ​ | ​ | ​ | ​                  | $ | -62,839 | ​ | ​ | ​ | ​                                 | $ | — | ​ | ​ | ​ | ​                         | $ | -62,058